Table 3.

Complications During Extracorporeal Life Support

	RSV	HSV	Adenovirus	CMV	Other
Bleeding, n (%)
Intracranial Infarct/bleeding	9 (12)	3 (23)	3 (25)	1 (12)	3 (25)
Gastrointestinal bleeding	2 (3)	1 (8)	1 (8)	1 (12)	1 (8)
Surgical site bleeding	20 (27)	1 (8)	1 (8)	1 (12)	4 (33)
Other bleeding	9 (12)	4 (31)*	3 (25)	1 (12)	2 (17)
Neurological, n (%)
Brain death	1 (1)	0	0	0	1 (8)
Seizures	10 (13)	4 (31)	4 (33)	2 (25)	2 (17)
Other neorological	2 (3)	4 (31)*	1 (8)	2 (25)*	0
Cardiopulmonary, n (%)
Required CPR	1 (1)	0	3 (25)*	1 (12)	2 (17)
Required inotropes	20 (26)	10 (76)†	4 (33)	4 (50)	4 (36)
Hypertension	9 (12)	2 (15)	1 (8)	3 (38)	3 (25)
Pneumothorax	9 (12)	2 (15)	0	1 (12)	0
Renal, n (%)
Cr >1.5 mg/dL	7 (9)	1 (8)	3 (25)	1 (12)	0
Cr >3.0 mg/dL	1 (1)	0	0	0	0
Required dialysis	25 (33)	5 (38)	8 (67)	1 (12)	4 (33)
*P<.05 versus RSV group. †P<.05 versus adenovirus group.

NOTE. The group termed “other” consists of patients with varicella, influenza, parainfluenza, and enterovirus. Figures are rounded to the nearest integer.

Adapted with permission.³